RNA Based Vaccine Market Regional Analysis and Competitive Landscape
The RNA based vaccine market exhibits distinct regional characteristics that reflect varying regulatory maturity, healthcare infrastructure, and biotechnology investment levels. North America retained market leadership with 38.2% of global share in 2025, underpinned by the United States' dominant position in RNA vaccine innovation, manufacturing, and commercialization. The U.S. hosts the...
0 Comments 0 Shares 2 Views 0 Reviews